Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
46
CORT Quote, Financials, Valuation and Earnings
Last price:
$68.59
Seasonality move
:
2.94%
Day range:
$65.07 - $68.87
52-week range:
$20.84 - $117.33
Dividend yield:
0%
P/E ratio:
55.34x
P/S ratio:
11.54x
P/B ratio:
10.65x
Volume:
1.1M
Avg. volume:
2M
1-year change:
188.08%
Market cap:
$7.2B
Revenue:
$675M
EPS (TTM):
$1.24
Earnings Data
Next earnings date for CORT
May 01
2025
Most recent earnings per share
$0.26
Missed by $0.16
(Feb 26/2025)
Consensus Estimate
$0.42
(Feb 26/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CORT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $216.7M | -- | -- | $0.38 | -- |
| 05/01/2025 | Q1 | $177.9M | -- | -- | $0.14 | -- |
| 02/26/2025 | Q4 | $200.1M | $181.9M | $0.26 | $0.42 | -$0.16 |
| 10/30/2024 | Q3 | $172M | $182.5M | $0.41 | $0.29 | $0.12 |
| 07/29/2024 | Q2 | $155.2M | $163.8M | $0.32 | $0.24 | $0.08 |
| 05/01/2024 | Q1 | $141.2M | $146.8M | $0.25 | $0.22 | $0.03 |
| 02/15/2024 | Q4 | $129.3M | $135.4M | $0.28 | $0.26 | $0.03 |
| 11/01/2023 | Q3 | -- | -- | $0.28 | $0.23 | $0.05 |
| 08/02/2023 | Q2 | -- | -- | $0.25 | $0.15 | $0.10 |
| 05/03/2023 | Q1 | -- | -- | $0.14 | $0.21 | -$0.07 |
| 02/28/2023 | Q4 | -- | -- | $0.14 | $0.28 | -$0.14 |
| 11/03/2022 | Q3 | -- | -- | $0.30 | $0.28 | $0.02 |
| 08/03/2022 | Q2 | -- | -- | $0.24 | $0.28 | -$0.04 |
| 05/05/2022 | Q1 | -- | -- | $0.20 | $0.31 | -$0.11 |
| 02/15/2022 | Q4 | -- | -- | $0.26 | $0.35 | -$0.09 |
| 11/03/2021 | Q3 | -- | -- | $0.24 | -- | -- |
| 07/29/2021 | Q2 | -- | -- | $0.21 | $0.17 | $0.05 |
| 05/06/2021 | Q1 | -- | -- | $0.18 | $0.19 | -$0.01 |
| 02/08/2021 | Q4 | -- | -- | $0.20 | $0.17 | $0.03 |
| 11/03/2020 | Q3 | -- | -- | $0.17 | $0.23 | -$0.06 |
| 08/04/2020 | Q2 | -- | -- | $0.23 | $0.21 | $0.02 |
| 05/04/2020 | Q1 | -- | -- | $0.25 | $0.21 | $0.04 |
| 02/20/2020 | Q4 | -- | -- | $0.24 | $0.26 | -$0.02 |
| 11/07/2019 | Q3 | -- | -- | $0.22 | $0.21 | $0.01 |
| 08/01/2019 | Q2 | -- | -- | $0.25 | $0.19 | $0.06 |
| 05/09/2019 | Q1 | -- | -- | $0.20 | $0.18 | $0.02 |
| 02/25/2019 | Q4 | -- | -- | $0.24 | $0.21 | $0.03 |
| 11/01/2018 | Q3 | -- | -- | $0.22 | $0.21 | $0.01 |
| 08/09/2018 | Q2 | -- | -- | $0.20 | $0.24 | -$0.04 |
| 05/08/2018 | Q1 | -- | -- | $0.19 | $0.18 | $0.02 |
| 02/22/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/02/2017 | Q3 | -- | -- | $0.14 | $0.14 | -- |
| 05/01/2017 | Q1 | -- | -- | -- | $0.03 | -- |
| 01/30/2017 | Q4 | -- | -- | -- | $0.05 | -- |
| 11/01/2016 | Q3 | -- | -- | $0.02 | $0.01 | $0.01 |
| 08/03/2016 | Q2 | -- | -- | $0.02 | $0.01 | $0.01 |
| 05/03/2016 | Q1 | -- | -- | $0.01 | $0.01 | -- |
| 11/05/2015 | Q3 | -- | -- | -- | -- | -- |
| 08/05/2015 | Q2 | -- | -- | -- | -- | -- |
Corcept Therapeutics Earnings Questions
-
How Much did Corcept Therapeutics Generate in Revenue Last Quarter?
Corcept Therapeutics reported $181.9M worth of top line sales in its most recent quarter.
-
Did Corcept Therapeutics Beat Earnings Last Quarter?
Corcept Therapeutics announced earnings per share of $0.26 which represents a miss of analyst forecast a $0.42 per share.
-
Is Corcept Therapeutics Profitable?
Corcept Therapeutics reported $178.9M that represents $1.50 per share over the last quarter.
-
What is the Analyst Consensus for Corcept Therapeutics EPS Next Year?
Corcept Therapeutics's earnings are forecast to grow from $1.23 per share to $1.70 per share next year representing an increase of 55.29%.
-
When is Corcept Therapeutics's Earnings Date?
Corcept Therapeutics's next earnings date is May 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
